ENTRADA THERAPEUTICS, INC. (TRDA) Net income 2020–2025
ENTRADA THERAPEUTICS, INC. (TRDA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$143.8MFY2025 · since FY2020: -$26.5M → -$143.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$143.8M | -319.0% |
| FY2024 | $65.6M | +1081.7% |
| FY2023 | -$6.7M | +92.9% |
| FY2022 | -$94.6M | -84.9% |
| FY2021 | -$51.2M | -92.9% |
| FY2020 | -$26.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TRDA financial trends
TRDA RevenueTRDA Net marginTRDA Gross profitTRDA Gross marginTRDA Operating incomeTRDA Operating marginTRDA Operating cash flowTRDA Free cash flowTRDA Capital expendituresTRDA Return on equityTRDA Stock buybacksTRDA Dividends paidTRDA Total assetsTRDA Total liabilitiesTRDA Shareholders’ equityTRDA overview →